Hawaii Senate Bill 507 (Prior Session Legislation)

---

Spectrum: Strong Partisan Bill (Democrat 12-1)
Status: Introduced on January 18 2019 - 25% progression, died in committee
Action: 2019-01-24 - Referred to CPH, WAM.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]

Requires pharmacy benefit managers to notify contracting pharmacies of changes to maximum allowable costs for any drug, identified by its National Drug Code, fifteen days prior to the change. Requires pharmacy benefit managers to disclose where an equivalent drug can be obtained at or below the maximum allowable cost, when a maximum allowable cost appeal is upheld on appeal. Requires pharmacy benefit managers to: allow contracting pharmacies to reverse and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost that is denied on appeal; and pay the difference to the contracting pharmacies. Permits contracting pharmacies to decline to dispense a drug if the reimbursement is less than the acquisition cost. Permits the insurance commissioner to revoke a pharmacy benefit manager's registration if the manager does not comply with state law. Requires the Department of Health to annually report to the legislature and any other state agency on appeals and disposition.

Relating To Pharmacy Benefit Managers.

Sen. Donna Kim [D]	Sen. Kalani English [D]	Sen. Kurt Fevella [R]	Sen. Breene Harimoto [D]
Sen. Les Ihara [D]	Sen. Kaiali'i Kahele [D]	Sen. Gil Keith-agaran [D]	Sen. Jarrett Keohokalole [D]
Sen. Sharon Moriwaki [D]	Sen. Gil Riviere [D]	Sen. Russell Ruderman [D]	Sen. Maile Shimabukuro [D]
Sen. Laura Thielen [D]

Date	Chamber	Action
2019-01-24	Senate	Referred to CPH, WAM.
2019-01-22	Senate	Passed First Reading.
2019-01-18	Senate	Introduced.

SB507 (Carry Over) 2019-01-24 - Referred to CPH, WAM.

Type	Source
Summary	https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=507&year=2019
Text	https://www.capitol.hawaii.gov/session2019/bills/SB507_.HTM